INSULIN GLULISINE (Apidra®)

Clinical Indication

Type 1 and 2 diabetes

Comments

Conditional on prescriber being competent to select appropriate patients

Date of classification

February 2019

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.